Concarlo Holdings, LLC

Biotechnology company · Brooklyn, New York, United States

Concarlo Holdings, LLC is a biotechnology company headquartered in Brooklyn, New York, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $320,217 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $450,000 sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

Concarlo Holdings at a glance

Typebiotechnology company

HeadquartersBrooklyn, New York, United States

Employees (self-reported, 2020)2

SEC CIK1701751

What does Concarlo Holdings do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $320,217 in total (2020). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $450,000 sold (2017).

Frequently asked questions about Concarlo Holdings

Where is Concarlo Holdings headquartered?

Concarlo Holdings, LLC is headquartered in Brooklyn, New York, United States.

What does Concarlo Holdings do?

Concarlo Holdings, LLC is a biotechnology company.

Similar companies

Phoenix Nest Inc.Brooklyn, New York, United States
Chemitope Glycopeptide Inc.Brooklyn, New York, United States
Accutar Biotechnology Inc.Brooklyn, New York, United States
Loki Therapeutics, IncBrooklyn, New York, United States
Lucerna IncBrooklyn, New York, United States
Xylyx Bio, Inc.Brooklyn, New York, United States
Fesariustherapeutics IncBrooklyn, New York, United States
Calder Biosciences Inc.Brooklyn, New York, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences